LifeGene-Biomarks, Inc. awarded a $100,000 NIH SBIR Phase I Cash Match from the Puerto Rico Science, Technology and Research Trust.

The Puerto Rico Science, Technology and Research Trust awards a $100,000 NIH SBIR Phase I Cash Match to LifeGene-Biomarks, Inc. to conduct research and development under the project titled:  Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings, funded by the National Cancer Institute.